-
1
-
-
16244412245
-
Coronary restenosis after implantation of drug-eluting stents
-
Schofer J, Schluter M. Coronary restenosis after implantation of drug-eluting stents. Minerva Cardioangiol 2005;53:43-48.
-
(2005)
Minerva Cardioangiol
, vol.53
, pp. 43-48
-
-
Schofer, J.1
Schluter, M.2
-
2
-
-
0035940376
-
Stent In Small Arteries (SISA) Trial Investigators. Stent placement to prevent restenosis after angioplasty in small coronary arteries
-
Doucet S, Schalij MJ, Vrolix MC, Hilton D, Chenu P, de Bruyne B, et al. Stent In Small Arteries (SISA) Trial Investigators. Stent placement to prevent restenosis after angioplasty in small coronary arteries. Circulation 2001;104:2029-2033.
-
(2001)
Circulation
, vol.104
, pp. 2029-2033
-
-
Doucet, S.1
Schalij, M.J.2
Vrolix, M.C.3
Hilton, D.4
Chenu, P.5
de Bruyne, B.6
-
3
-
-
4644226291
-
Drug-eluting stents: The end of restenosis?
-
Wong A, Chan C. Drug-eluting stents: The end of restenosis? Ann Acad Med Singapore 2004;33:423-431.
-
(2004)
Ann Acad Med Singapore
, vol.33
, pp. 423-431
-
-
Wong, A.1
Chan, C.2
-
4
-
-
0037469230
-
Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus eluting stents in human coronary arteries
-
Sousa JE, Costa MA, Sousa AG, Abizaid AC, Seixas AC, Abizaid AS, et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus eluting stents in human coronary arteries. Circulation 2003;107:381-383.
-
(2003)
Circulation
, vol.107
, pp. 381-383
-
-
Sousa, J.E.1
Costa, M.A.2
Sousa, A.G.3
Abizaid, A.C.4
Seixas, A.C.5
Abizaid, A.S.6
-
5
-
-
0037422604
-
TAXUS I: Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions
-
Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerekens U, et al. TAXUS I: Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003;7:38-42.
-
(2003)
Circulation
, vol.7
, pp. 38-42
-
-
Grube, E.1
Silber, S.2
Hauptmann, K.E.3
Mueller, R.4
Buellesfeld, L.5
Gerekens, U.6
-
6
-
-
0036731954
-
No delayed restenosis at 18 months after implantation of sirolimus-eluting stent
-
Tanabe K, Degertekin M, Regar E, Ligthart JM, van der Giessen WJ, Serruys PW. No delayed restenosis at 18 months after implantation of sirolimus-eluting stent. Catheter Cardiovasc Interv 2002;57:65-68.
-
(2002)
Catheter Cardiovasc Interv
, vol.57
, pp. 65-68
-
-
Tanabe, K.1
Degertekin, M.2
Regar, E.3
Ligthart, J.M.4
van der Giessen, W.J.5
Serruys, P.W.6
-
7
-
-
0345596451
-
Cell replication in the arterial wall: Activation of signaling pathway following in vivo injury
-
Koyama H, Olson NE, Dastvan FF, Reidy MA. Cell replication in the arterial wall: Activation of signaling pathway following in vivo injury. Circ Res 1998;82:713-721.
-
(1998)
Circ Res
, vol.82
, pp. 713-721
-
-
Koyama, H.1
Olson, N.E.2
Dastvan, F.F.3
Reidy, M.A.4
-
8
-
-
10844258492
-
-
Yue TL, Vickery-Clark L, Louden CS, Gu JL, Ma XL, Narayanan PK, et al. Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization, and inhibits neointimal formation in vivo after vascular injury. Circulation 2000;102:III281-III288.
-
Yue TL, Vickery-Clark L, Louden CS, Gu JL, Ma XL, Narayanan PK, et al. Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization, and inhibits neointimal formation in vivo after vascular injury. Circulation 2000;102:III281-III288.
-
-
-
-
9
-
-
0033602680
-
Effects of equine oestrogens on markers of vasoactive function in human coronary artery endothelial cells
-
Wingrove CS, Garr E, Pickar JH, Dey M, Stevenson JC. Effects of equine oestrogens on markers of vasoactive function in human coronary artery endothelial cells. Mol Cell Endocrinol 1999;150:33-37.
-
(1999)
Mol Cell Endocrinol
, vol.150
, pp. 33-37
-
-
Wingrove, C.S.1
Garr, E.2
Pickar, J.H.3
Dey, M.4
Stevenson, J.C.5
-
10
-
-
0030901572
-
Estradiol accelerates functional endothelial recovery after arterial injury
-
Krasinski K, Spyridopoulos I, Asahara T, van der Zee R, Isner JM, Losordo DW. Estradiol accelerates functional endothelial recovery after arterial injury. Circulation 1997;95:1768-1772.
-
(1997)
Circulation
, vol.95
, pp. 1768-1772
-
-
Krasinski, K.1
Spyridopoulos, I.2
Asahara, T.3
van der Zee, R.4
Isner, J.M.5
Losordo, D.W.6
-
11
-
-
0034669450
-
Local delivery of 17-β-estradiol decreases neointimal hyperplasia after coronary angioplasty in a porcine model
-
Chandrasekar B, Tanguay JF. Local delivery of 17-β-estradiol decreases neointimal hyperplasia after coronary angioplasty in a porcine model. J Am Coll Cardiol 2000;36:1972-1978.
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 1972-1978
-
-
Chandrasekar, B.1
Tanguay, J.F.2
-
12
-
-
0036790743
-
Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model
-
New G, Moses JW, Roubin GS, Leon MB, Colombo A, Iyer SS, Tio FO, Mehran R, Kipshidze N. Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model. Catheter Cardiovasc Interv 2002;57:266-271.
-
(2002)
Catheter Cardiovasc Interv
, vol.57
, pp. 266-271
-
-
New, G.1
Moses, J.W.2
Roubin, G.S.3
Leon, M.B.4
Colombo, A.5
Iyer, S.S.6
Tio, F.O.7
Mehran, R.8
Kipshidze, N.9
-
13
-
-
12144288415
-
First human experience with the 17-β-estradiol-eluting stent: The estrogen and stents to eliminate restenosis (EASTER) trial
-
Abizaid A, Albertal M, Costa MA, Abizaid AS, Staico R, Feres F, et al. First human experience with the 17-β-estradiol-eluting stent: The estrogen and stents to eliminate restenosis (EASTER) trial. J Am Coll Cardiol 2004;43:1118-1121.
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 1118-1121
-
-
Abizaid, A.1
Albertal, M.2
Costa, M.A.3
Abizaid, A.S.4
Staico, R.5
Feres, F.6
-
14
-
-
0036786031
-
Coronary artery stretch versus deep injury in the development of in-stent neointima
-
Gunn J, Arnold N, Chan KH, Shepherd L, Cumberland DC, Crossman DC. Coronary artery stretch versus deep injury in the development of in-stent neointima. Heart 2002;88:401-405.
-
(2002)
Heart
, vol.88
, pp. 401-405
-
-
Gunn, J.1
Arnold, N.2
Chan, K.H.3
Shepherd, L.4
Cumberland, D.C.5
Crossman, D.C.6
-
15
-
-
0031760585
-
Intravascular stents: A new technique for tissue processing for histology, immunohistochemistry, and transmission electron microscopy
-
Malik N, Gunn J, Holt CM, Shepherd L, Francis SE, Newman CM, et al. Intravascular stents: A new technique for tissue processing for histology, immunohistochemistry, and transmission electron microscopy. Heart 1998;80:509-516.
-
(1998)
Heart
, vol.80
, pp. 509-516
-
-
Malik, N.1
Gunn, J.2
Holt, C.M.3
Shepherd, L.4
Francis, S.E.5
Newman, C.M.6
-
17
-
-
23944463886
-
17-β-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease
-
Airoldi F, Di Mario C, Ribichini F, Presbitero P, Sganzerla P, Ferrero V, et al. 17-β-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease. Am J Cardiol 2005;96:664-667.
-
(2005)
Am J Cardiol
, vol.96
, pp. 664-667
-
-
Airoldi, F.1
Di Mario, C.2
Ribichini, F.3
Presbitero, P.4
Sganzerla, P.5
Ferrero, V.6
-
19
-
-
0032485849
-
Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery
-
Kim S, Izumi Y, Yano M, Hamaguchi A, Miura K, Yamanaka S, et al. Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery. Circulation 1998;97:1731-1737.
-
(1998)
Circulation
, vol.97
, pp. 1731-1737
-
-
Kim, S.1
Izumi, Y.2
Yano, M.3
Hamaguchi, A.4
Miura, K.5
Yamanaka, S.6
-
20
-
-
0031471951
-
Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury
-
Hu Y, Cheng L, Hochleitner BW, Xu Q. Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler Thromb Vasc Biol 1997;17:2808-2816.
-
(1997)
Arterioscler Thromb Vasc Biol
, vol.17
, pp. 2808-2816
-
-
Hu, Y.1
Cheng, L.2
Hochleitner, B.W.3
Xu, Q.4
-
21
-
-
0034907636
-
Pharmacologic interruption of the mitogen-activated extracellular regulated kinase/mitogen activated protein kinase signal transduction pathway: Potential role in promoting cytotoxic drug action
-
Dent P, Grant S. Pharmacologic interruption of the mitogen-activated extracellular regulated kinase/mitogen activated protein kinase signal transduction pathway: Potential role in promoting cytotoxic drug action. Clin Cancer Res 2001;7:775-783.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 775-783
-
-
Dent, P.1
Grant, S.2
-
22
-
-
0033807228
-
Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling
-
Houslay MD, Kolch W. Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol Pharmacol 2000;58:659-668.
-
(2000)
Mol Pharmacol
, vol.58
, pp. 659-668
-
-
Houslay, M.D.1
Kolch, W.2
-
24
-
-
0345169806
-
Drug-eluting intra-coronary stents: Have we got the magic bullet
-
Bhatia V, Bhatia R, Dhindsa S. Drug-eluting intra-coronary stents: Have we got the magic bullet. J Postgrad Med 2003;49:291-296.
-
(2003)
J Postgrad Med
, vol.49
, pp. 291-296
-
-
Bhatia, V.1
Bhatia, R.2
Dhindsa, S.3
|